A Comparative Trial of Calcitriol Versus Placebo for the Preservation of Bone Mass and Strength After Kidney Transplantation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Calcitriol (Primary)
- Indications Bone disorders
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 30 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 20 Jun 2016 The patients age range has been changed from ≥40 years to ≥18 years.